세계의 일회용 주사기 시장 규모, 점유율, 동향 분석 보고서 : 유형별, 용도별, 최종 용도별, 지역별, 예측(2025-2033년)

Disposable Syringes Market Summary

The global disposable syringes market size was estimated at USD 15.81 billion in 2024 and is projected to reach USD 28.27 billion by 2033, growing at a CAGR of 6.8% from 2025 to 2033. The growth can be attributed to the increasing incidence of chronic diseases and rising technological advancements.

Moreover, the growing adoption of safety syringes and the rising prevalence of diabetes are anticipated to drive market growth. According to the International Diabetes Federation (IDF), around 853 million individuals will have diabetes by 2050.

Furthermore, supportive initiatives from manufacturers and the government to encourage the use of disposable syringes are anticipated to fuel the market growth in the coming years. For instance, in March 2024, Hindustan Syringes and Medical Devices, a manufacturer of auto-disable and disposable syringes, introduced the Dispojekt single-use syringe to protect against needlestick injuries.

Moreover, the government of India has undertaken the manufacturing of disposable syringes, which is under development in Assam. This project costs around USD 0.63 million. Thus, the rising focus of the government on syringe manufacturing and growing expenditures for increasing syringe production are anticipated to boost the market growth over the forecast period.

In addition, reusing of syringes leads to the risk of contracting Hepatitis B, Hepatitis C, HIV, and many other blood-borne pathogens. The high burden of infectious diseases, such as HIV infection, which may be acquired via reused injectables among people, likely to increase the demand for disposable syringes. This, in turn, is anticipated to propel market growth over the forecast period. According to the study published by the National Library Of Medicine in May 2023, the sharing of needles/syringes is positively associated with HIV infection. Hence, to prevent the spread of such infections, the adoption of disposable syringes is anticipated to increase, thus contributing to the market's growth.

Global Disposable Syringes Market Report Segmentation

This report forecasts revenue growth at global, regional, and country levels and provides an analysis on the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global disposable syringes market report based on type, application, end use, and region:

• Type Outlook (Revenue, USD Million, 2021 - 2033)
• Conventional Syringes
• Safety Syringes
  • Retractable Safety Syringes
  • Non-retractable Safety Syringes
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Vaccines and immunizations
• Anaphylaxis
• Rheumatoid Arthritis
• Diabetes
• Autoimmune diseases
• Oncology
• Others
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Hospital
• Diagnostic Laboratories
• Blood Banks
• Pharmaceutical Industry
• Veterinary purposes
• Others
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Type
  • 1.1.2. Application
  • 1.1.3. End-use
  • 1.1.4. Regional scope
  • 1.1.5. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives
  • 1.9.1. Objective 1
  • 1.9.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Disposable Syringes Market Variables, Trends, & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Ancillary Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing Prevalence Of Chronic Disorders
    • 3.2.1.2. Growing Adoption Of Safety Syringes
    • 3.2.1.3. Investment In Production Facilities
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. Stringent Regulatory Policies And Regulations
  • 3.2.3. Market Opportunities Analysis
    • 3.2.3.1. Increasing Demand Of Injectable Drugs
    • 3.2.3.2. Growing Number Of Clinical Trials
    • 3.2.3.3. Advancements In Products
  • 3.2.4. Market Challenge Analysis
    • 3.2.4.1. Product Recalls
• 3.3. Disposable Syringes Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape

Chapter 4. Disposable Syringes Market: Type Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Disposable Syringes Market Movement Analysis
• 4.3. Global Disposable Syringes Market Size & Trend Analysis, by Type, 2021 to 2033 (USD Million)
• 4.4. Conventional Syringes
  • 4.4.1. Conventional Syringes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Safety Syringes
  • 4.5.1. Safety Syringes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.1.1. Retractable Safety Syringes
      • 4.5.1.1.1. Retractable Safety Syringes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
    • 4.5.1.2. Non-retractable Safety Syringes
      • 4.5.1.2.1. Non-retractable Safety Syringes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Disposable Syringes Market: Application Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Disposable Syringes Market Movement Analysis
• 5.3. Global Disposable Syringes Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 5.4. Vaccines and immunizations
  • 5.4.1. Vaccines and Immunizations Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. Anaphylaxis
  • 5.5.1. Anaphylaxis Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. Rheumatoid Arthritis
  • 5.6.1. Rheumatoid Arthritis Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.7. Diabetes
  • 5.7.1. Diabetes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.8. Autoimmune diseases
  • 5.8.1. Autoimmune diseases Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.9. Oncology
  • 5.9.1. Oncology Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.10. Others
  • 5.10.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Disposable Syringes Market: End Use Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Disposable Syringes Market Movement Analysis
• 6.3. Global Disposable Syringes Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 6.4. Hospital
  • 6.4.1. Hospital Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Diagnostic Laboratories
  • 6.5.1. Diagnostic Laboratories Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Blood Banks
  • 6.6.1. Blood Banks Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.7. Pharmaceutical Industry
  • 6.7.1. Pharmaceutical Industry Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.8. Veterinary purposes
  • 6.8.1. Veterinary purposes Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.9. Others
  • 6.9.1. Others Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Disposable Syringes Market: Regional Estimates & Trend Analysis By Type, By Application, By End Use

• 7.1. Regional Dashboard
• 7.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
• 7.3. North America
  • 7.3.1. North America Disposable Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.3.2. U.S.
    • 7.3.2.1. Key Country Dynamics
    • 7.3.2.2. Competitive Scenario
    • 7.3.2.3. Regulatory Scenario
    • 7.3.2.4. Reimbursement Scenario
    • 7.3.2.5. U.S. Disposable Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.3.3. Canada
    • 7.3.3.1. Key Country Dynamics
    • 7.3.3.2. Competitive Scenario
    • 7.3.3.3. Regulatory Scenario
    • 7.3.3.4. Reimbursement Scenario
    • 7.3.3.5. Canada Disposable Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.3.4. Mexico
    • 7.3.4.1. Key Country Dynamics
    • 7.3.4.2. Competitive Scenario
    • 7.3.4.3. Regulatory Scenario
    • 7.3.4.4. Reimbursement Scenario
    • 7.3.4.5. Mexico Disposable Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.4. Europe
  • 7.4.1. Europe Disposable Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.2. UK
    • 7.4.2.1. Key Country Dynamics
    • 7.4.2.2. Competitive Scenario
    • 7.4.2.3. Regulatory Scenario
    • 7.4.2.4. Reimbursement Scenario
    • 7.4.2.5. UK Disposable Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.3. Germany
    • 7.4.3.1. Key Country Dynamics
    • 7.4.3.2. Competitive Scenario
    • 7.4.3.3. Regulatory Scenario
    • 7.4.3.4. Reimbursement Scenario
    • 7.4.3.5. Germany Disposable Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.4. France
    • 7.4.4.1. Key Country Dynamics
    • 7.4.4.2. Competitive Scenario
    • 7.4.4.3. Regulatory Scenario
    • 7.4.4.4. Reimbursement Scenario
    • 7.4.4.5. France Disposable Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.5. Italy
    • 7.4.5.1. Key Country Dynamics
    • 7.4.5.2. Competitive Scenario
    • 7.4.5.3. Regulatory Scenario
    • 7.4.5.4. Reimbursement Scenario
    • 7.4.5.5. Italy Disposable Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.6. Spain
    • 7.4.6.1. Key Country Dynamics
    • 7.4.6.2. Competitive Scenario
    • 7.4.6.3. Regulatory Scenario
    • 7.4.6.4. Reimbursement Scenario
    • 7.4.6.5. Spain Disposable Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.7. Denmark
    • 7.4.7.1. Key Country Dynamics
    • 7.4.7.2. Competitive Scenario
    • 7.4.7.3. Regulatory Scenario
    • 7.4.7.4. Reimbursement Scenario
    • 7.4.7.5. Denmark Disposable Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.8. Sweden
    • 7.4.8.1. Key Country Dynamics
    • 7.4.8.2. Competitive Scenario
    • 7.4.8.3. Regulatory Scenario
    • 7.4.8.4. Reimbursement Scenario
    • 7.4.8.5. Sweden Disposable Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.4.9. Norway
    • 7.4.9.1. Key Country Dynamics
    • 7.4.9.2. Competitive Scenario
    • 7.4.9.3. Regulatory Scenario
    • 7.4.9.4. Reimbursement Scenario
    • 7.4.9.5. Norway Disposable Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.5. Asia Pacific
  • 7.5.1. Asia Pacific Disposable Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.2. Japan
    • 7.5.2.1. Key Country Dynamics
    • 7.5.2.2. Competitive Scenario
    • 7.5.2.3. Regulatory Scenario
    • 7.5.2.4. Reimbursement Scenario
    • 7.5.2.5. Japan Disposable Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.3. China
    • 7.5.3.1. Key Country Dynamics
    • 7.5.3.2. Competitive Scenario
    • 7.5.3.3. Regulatory Scenario
    • 7.5.3.4. Reimbursement Scenario
    • 7.5.3.5. China Disposable Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.4. India
    • 7.5.4.1. Key Country Dynamics
    • 7.5.4.2. Competitive Scenario
    • 7.5.4.3. Regulatory Scenario
    • 7.5.4.4. Reimbursement Scenario
    • 7.5.4.5. India Disposable Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.5. South Korea
    • 7.5.5.1. Key Country Dynamics
    • 7.5.5.2. Competitive Scenario
    • 7.5.5.3. Regulatory Scenario
    • 7.5.5.4. Reimbursement Scenario
    • 7.5.5.5. South Korea Disposable Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.6. Australia
    • 7.5.6.1. Key Country Dynamics
    • 7.5.6.2. Competitive Scenario
    • 7.5.6.3. Regulatory Scenario
    • 7.5.6.4. Reimbursement Scenario
    • 7.5.6.5. Australia Disposable Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5.7. Thailand
    • 7.5.7.1. Key Country Dynamics
    • 7.5.7.2. Competitive Scenario
    • 7.5.7.3. Regulatory Scenario
    • 7.5.7.4. Reimbursement Scenario
    • 7.5.7.5. Thailand Disposable Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.6. Latin America
  • 7.6.1. Latin America Disposable Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.2. Brazil
    • 7.6.2.1. Key Country Dynamics
    • 7.6.2.2. Competitive Scenario
    • 7.6.2.3. Regulatory Scenario
    • 7.6.2.4. Reimbursement Scenario
    • 7.6.2.5. Brazil Disposable Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6.3. Argentina
    • 7.6.3.1. Key Country Dynamics
    • 7.6.3.2. Competitive Scenario
    • 7.6.3.3. Regulatory Scenario
    • 7.6.3.4. Reimbursement Scenario
    • 7.6.3.5. Argentina Disposable Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.7. Middle East & Africa
  • 7.7.1. Middle East & Africa Disposable Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.2. South Africa
    • 7.7.2.1. Key Country Dynamics
    • 7.7.2.2. Competitive Scenario
    • 7.7.2.3. Regulatory Scenario
    • 7.7.2.4. Reimbursement Scenario
    • 7.7.2.5. South Africa Disposable Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.3. Saudi Arabia
    • 7.7.3.1. Key Country Dynamics
    • 7.7.3.2. Competitive Scenario
    • 7.7.3.3. Regulatory Scenario
    • 7.7.3.4. Reimbursement Scenario
    • 7.7.3.5. Saudi Arabia Disposable Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.4. UAE
    • 7.7.4.1. Key Country Dynamics
    • 7.7.4.2. Competitive Scenario
    • 7.7.4.3. Regulatory Scenario
    • 7.7.4.4. Reimbursement Scenario
    • 7.7.4.5. UAE Disposable Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7.5. Kuwait
    • 7.7.5.1. Key Country Dynamics
    • 7.7.5.2. Competitive Scenario
    • 7.7.5.3. Regulatory Scenario
    • 7.7.5.4. Reimbursement Scenario
    • 7.7.5.5. Kuwait Disposable Syringes Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

• 8.1. Recent Developments & Impact Analysis, By Key Market Participants
• 8.2. Company/Competition Categorization
  • 8.2.1. Innovators
• 8.3. Vendor Landscape
  • 8.3.1. List of key distributors and channel partners
  • 8.3.2. Key customers
  • 8.3.3. Global Key company market share analysis, 2024
  • 8.3.4. NIPRO
    • 8.3.4.1. Company Overview
    • 8.3.4.2. Financial Performance
    • 8.3.4.3. Service Benchmarking
    • 8.3.4.4. Strategic Initiatives
  • 8.3.5. SMB Corporation of India
    • 8.3.5.1. Company Overview
    • 8.3.5.2. Financial Performance
    • 8.3.5.3. Service Benchmarking
    • 8.3.5.4. Strategic Initiatives
  • 8.3.6. Hindustan Syringes & Medical Devices Ltd
    • 8.3.6.1. Company Overview
    • 8.3.6.2. Financial Performance
    • 8.3.6.3. Service Benchmarking
    • 8.3.6.4. Strategic Initiatives
  • 8.3.7. B. Braun Medical Inc.
    • 8.3.7.1. Company Overview
    • 8.3.7.2. Financial Performance
    • 8.3.7.3. Product Benchmarking
    • 8.3.7.4. Strategic Initiatives
  • 8.3.8. BD
    • 8.3.8.1. Company Overview
    • 8.3.8.2. Financial Performance
    • 8.3.8.3. Product Benchmarking
    • 8.3.8.4. Strategic Initiatives
  • 8.3.9. Vita Needle Company
    • 8.3.9.1. Company Overview
    • 8.3.9.2. Financial Performance
    • 8.3.9.3. Product Benchmarking
    • 8.3.9.4. Strategic Initiatives
  • 8.3.10. Terumo Corporation
    • 8.3.10.1. Company Overview
    • 8.3.10.2. Financial Performance
    • 8.3.10.3. Product Benchmarking
    • 8.3.10.4. Strategic Initiatives
  • 8.3.11. Cardinal Health
    • 8.3.11.1. Company Overview
    • 8.3.11.2. Financial Performance
    • 8.3.11.3. Product Benchmarking
    • 8.3.11.4. Strategic Initiatives
  • 8.3.12. ulti med Products
    • 8.3.12.1. Company Overview
    • 8.3.12.2. Financial Performance
    • 8.3.12.3. Product Benchmarking
    • 8.3.12.4. Strategic Initiatives
  • 8.3.13. Henke Sass Wolf GmbH
    • 8.3.13.1. Company Overview
    • 8.3.13.2. Financial Performance
    • 8.3.13.3. Product Benchmarking
    • 8.3.13.4. Strategic Initiatives
  • 8.3.14. Retractable Technologies, Inc.
    • 8.3.14.1. Company Overview
    • 8.3.14.2. Financial Performance
    • 8.3.14.3. Product Benchmarking
    • 8.3.14.4. Strategic Initiatives
  • 8.3.15. kohope.com
    • 8.3.15.1. Company Overview
    • 8.3.15.2. Financial Performance
    • 8.3.15.3. Product Benchmarking
    • 8.3.15.4. Strategic Initiatives
  • 8.3.16. Liaoning Kangyi Medical Equipment Co., Ltd
    • 8.3.16.1. Company Overview
    • 8.3.16.2. Financial Performance
    • 8.3.16.3. Product Benchmarking
    • 8.3.16.4. Strategic Initiatives
  • 8.3.17. Lifelong Meditech Private Limited.
    • 8.3.17.1. Company Overview
    • 8.3.17.2. Financial Performance
    • 8.3.17.3. Product Benchmarking
    • 8.3.17.4. Strategic Initiatives
  • 8.3.18. OSAKA CHEMICAL Co.,Ltd.
    • 8.3.18.1. Company Overview
    • 8.3.18.2. Financial Performance
    • 8.3.18.3. Product Benchmarking
    • 8.3.18.4. Strategic Initiatives
  • 8.3.19. JMS Co.Ltd
    • 8.3.19.1. Company Overview
    • 8.3.19.2. Financial Performance
    • 8.3.19.3. Product Benchmarking
    • 8.3.19.4. Strategic Initiatives
  • 8.3.20. APEX MEDICAL DEVICES
    • 8.3.20.1. Company Overview
    • 8.3.20.2. Financial Performance
    • 8.3.20.3. Product Benchmarking
    • 8.3.20.4. Strategic Initiatives
  • 8.3.21. Cartel Health Care Pvt. Ltd
    • 8.3.21.1. Company Overview
    • 8.3.21.2. Financial Performance
    • 8.3.21.3. Product Benchmarking
    • 8.3.21.4. Strategic Initiatives
  • 8.3.22. Hi-Tech Syringes
    • 8.3.22.1. Company Overview
    • 8.3.22.2. Financial Performance
    • 8.3.22.3. Product Benchmarking
    • 8.3.22.4. Strategic Initiatives
  • 8.3.23. VEM Tooling Co.,Ltd. (VEM Thailand Co. Ltd)
    • 8.3.23.1. Company Overview
    • 8.3.23.2. Financial Performance
    • 8.3.23.3. Product Benchmarking
    • 8.3.23.4. Strategic Initiatives
• 8.4. Heat Map Analysis/ Company Market Position Analysis
• 8.5. Estimated Company Market Share Analysis, 2024
• 8.6. List of Other Key Market Players